Pinnacle Associates LTD Coll Plant Biotechnologies LTD Transaction History
Pinnacle Associates LTD
- $7.08 Billion
- Q4 2024
A detailed history of Pinnacle Associates LTD transactions in Coll Plant Biotechnologies LTD stock. As of the latest transaction made, Pinnacle Associates LTD holds 489,693 shares of CLGN stock, worth $1.71 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
489,693
Previous 468,109
4.61%
Holding current value
$1.71 Million
Previous $2.33 Million
23.17%
% of portfolio
0.03%
Previous 0.04%
Shares
7 transactions
Others Institutions Holding CLGN
# of Institutions
17Shares Held
2.05MCall Options Held
0Put Options Held
0-
Villere St Denis J & CO LLC484KShares$1.69 Million0.17% of portfolio
-
Investment Management Of Virginia LLC464KShares$1.62 Million0.63% of portfolio
-
Roumell Asset Management, LLC Chevy Chase, MD276KShares$967,5052.69% of portfolio
-
Brown Advisory Inc119KShares$418,1270.0% of portfolio
-
Amh Equity LTD117KShares$407,7500.46% of portfolio
About CollPlant Biotechnologies Ltd
- Ticker CLGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,086,500
- Market Cap $38.8M
- Description
- CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, and Europe. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering tech...